We’re thrilled to welcome Ugochi Owo, founder and CEO of Flindel, as a strategic advisor to BioVie. Ugochi brings an entrepreneurial mindset, a deep personal connection to the Alzheimer’s community, and a unique ability to build meaningful networks. Her passion for innovation and connecting people aligns powerfully with our mission to address some of today’s pressing unmet medical needs – including treatments for Alzheimer’s disease, Parkinson’s disease and long COVID – by targeting neuroinflammation at its source. Along with strategic know-how, Ugochi is a dedicated philanthropist, working with World Vision to provide quality education and resources for underprivileged children and to bridge socioeconomic gaps. Her insight and advocacy will be invaluable as we continue advancing therapies that have the potential to change lives. Welcome to the team, Ugochi! #Neurology #AlzheimersDisease #ParkinsonsDisease #LongCOVID
CEO at BioVie | Innovations in Neurodegeneration & Aging-Related Disorders | Founder & Chairman at M6P Therapeutics
Ugochi Owo is a serial entrepreneur and the CEO of Flindel. She knows firsthand the toll that Alzheimer’s takes on families—and she has a superpower: connecting people. Ugochi believes in our mission to modulate #neuroinflammation to address the challenges of #Alzheimer’s, #Parkinson’s, and #LongCovid. I’m excited to work with her to help spread the word that neuroinflammation may be at the root of many health issues.